ArticleAJOG global reports2026
Evaluation of diagnostic and therapeutic hysteroscopy outcomes at a tertiary hospital in Rwanda.
Article in AJOG global reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Hysteroscopy is a minimally invasive technique for diagnosing and managing intrauterine pathologies, critical in addressing reproductive health issues. In Rwanda, limited data exist regarding the practice and outcomes of hysteroscopic procedures. Therefore, the objective of this study is to evaluate the practice, diagnostic and therapeutic outcomes, and patient-reported results of hysteroscopy performed at the University Teaching Hospital of Kigali (CHUK) from March 2022 to February 2025. Methods: This retrospective and prospective study included 62 women who underwent hysteroscopy at CHUK. Data collected encompassed demographic details, indications, procedural characteristics, outcomes, and follow-up outcomes. Descriptive statistics and bivariate analyses assessed clinical findings, complication rates, efficacy of treatments, and factors associated with symptom improvement. Results: A total of 62 women underwent hysteroscopic procedures within the study period. The mean age was 42 years (±6.4 years), with 74% aged between 30 and 50 years. Most participants were premenopausal (74%) and had attained at least secondary education (50%). The predominant indications for hysteroscopy were abnormal uterine bleeding (59.68%) and infertility (25.8%). Diagnostic hysteroscopy accounted for 52.2% of cases, while therapeutic procedures comprised 46.8%. The most common hysteroscopic findings included endometrial polyps (33.9%), intrauterine adhesions (16.1%), and fibroids (16.1%), with 25.8% showing a normal cavity. The majority of procedures (77.4%) lasted less than an hour, and the complication rate was 4.8%. Most patients (72.6%) had their intrauterine pathology successfully treated during the procedure. Conclusions: Hysteroscopy in Rwanda demonstrates favorable diagnostic yield and therapeutic outcomes, with minimal complications. The increasing adoption of office-based procedures and targeted management of intrauterine lesions can enhance patient care. These findings support the expansion of hysteroscopic services and capacity building in the region.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.